From the Editor-in-Chief
Can cancer's dependence on sugar help researchers find new targets to treat the disease?
by William G. Nelson, MD, PhD
Your Tax Dollars at Work | Treatment Before Surgery | Opportunities for Prevention | Tinkering With T Cells | Palliative Care Can Help a Wide Range of Patients | Improving Patient Care Worldwide
Learn what questions to ask before participating in a study.
by Hester Hill Schnipper
Caregiving With Confidence
Shifting some responsibilities may empower your loved one and strengthen your relationship.
by Aimee Swartz
Researchers are testing treatment vaccines that spur the immune system to attack cancer.
by Stephen Ornes
Successful public health initiatives to prevent, detect and treat cancer require widespread community participation.
by Marci A. Landsmann
Advocacy In Action
Lori Marx-Rubiner and AnneMarie Ciccarella met on social media and grew close through their cancer research advocacy.
by Sue Rochman
More children are being treated successfully for cancer. Yet researchers continue searching for new therapies that will help kids who don't respond to standard treatments.
by Cameron Walker
Vitamin D Doubts | A Virtuous Cycle
During her husband's treatment for metastatic prostate cancer, Jan Manarite learned what questions to ask. Now she shares what she learned with others.
Learn how to help a depressed parent with cancer.
Cancer survivor creates scholarship fund for young adult cancer survivors.
by Lindsey Konkel
Wanda Huskins, Renee Soriano, Holly Hamer.
Patients diagnosed with a second cancer may be unnecessarily excluded from clinical trials.
by Kate Yandell
Stock your bag with these useful items before your next infusion session.
by Jamie L. Schwachter
An updated site and a new digital editor means better and faster cancer coverage for our readers.
by Cancer Today Staff
Researcher speculates that costly genetic testing may be limiting outreach to underserved communities.
AACR leaders Margaret Foti, PhD, MD (hc), Elizabeth M. Jaffee, MD, and Elaine R. Mardis, PhD, share their stories.
The FDA expands use of durvalumab to non–small cell lung cancer.
Women who work the night shift may have an increased risk of developing some cancers.
The Financial Toll of Cancer
donate to the AACR